drugset
Drugs / TAA-specific cytotoxic T lymphocytes
last change Sep 2021 re-read 3 minutes ago

TAA-specific cytotoxic T lymphocytes

Cell therapy

Developed for
Hodgkins lymphoma · non-Hodgkin lymphoma
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · National Cancer Institute (NCI) · The Methodist Hospital Research Institute

Trials 1

today NCT01333046 · Ph 1
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01333046 Jan 2012 → Sep 2021 overdue Hodgkins lymphoma, non-Hodgkin lymphoma Baylor College of Medicine Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TAA-specific cytotoxic T lymphocytes “special immune system cells called tumor associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental therapy” NCT01333046 ↗
Modality Cell therapy “special types of T cells called cytotoxic T lymphocytes (CTLs) generated in the lab” NCT01333046 ↗
Route Intravenous “The cells will be injected by IV over 10 minutes.” NCT01333046 ↗